
Loading, please wait...

Loading, please wait...

Recent research into Mpox virus immune evasion has identified the D8L protein as a critical factor in suppressing host defenses. In August 2024, health authorities declared mpox a public health emergency. However, scientists previously had limited knowledge regarding how specific viral proteins interact with the innate immune system. This new study clarifies that the D8L protein effectively inhibits the interferon (IFN)-mediated antiviral response.
Mechanistically, the D8L protein prevents antiviral immune responses by interacting directly with the signal transducer and activator of transcription 1 (STAT1). Specifically, D8L binds to the SH2 structural domain of STAT1 but does not interact with other regions. Consequently, this binding blocks the phosphorylation and subsequent nuclear translocation of the STAT1 protein. Therefore, the virus successfully halts the signaling cascade required to activate protective genes.
Furthermore, the suppression of STAT1 results in significantly lower mRNA transcription of several essential interferon-stimulated genes (ISGs). These suppressed genes include Cig5, MX2, ISG56, IFITM1, OAS1, and ISG15. By neutralizing these components, the virus bypasses the host's primary innate barriers. In addition, the researchers identified specific point-mutant plasmids, such as D8L-9-11, D8L-13, and D8L-18, which retain the ability to bind STAT1.
Ultimately, these findings provide a biological roadmap for developing novel antiviral therapies. By targeting the D8L-STAT1 interaction, clinicians may eventually be able to restore the efficacy of the host’s natural interferon response. Such breakthroughs are vital for managing outbreaks and improving patient outcomes in the face of evolving orthopoxviruses.
The D8L protein acts as an antagonist to the host immune system. It binds to the STAT1 protein, which prevents the cell from responding to interferon signals that would normally stop viral replication.
D8L suppresses the expression of several interferon-stimulated genes, including ISG15, OAS1, MX2, and IFITM1. These genes are crucial for establishing an antiviral state within host cells.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Zhou H et al. Mpox virus D8L protein binds to STAT1 and inhibits its phosphorylation to antagonize IFN-induced signaling. Cell Commun Signal. 2026 May 14. doi: 10.1186/s12964-026-02931-y. PMID: 42135820.
World Health Organization. Mpox (monkeypox). Fact sheet. Published October 2024. Accessed May 15, 2026.
Saghazadeh A, Rezaei N. The evolving mpox threat (2022-2024): clade dynamics, immune evasion, and escalating global health challenges. Cell Commun Signal. 2024;22(1):15. doi:10.1186/s12964-023-01438-w.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research shows the Mpox virus D8L protein binds to STAT1, inhibiting its phosphorylation and blocking the host's antiviral interferon-mediated response....
5 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today